Mathieu Angleys is a Medical Affairs Professional at Eli Lilly and Company, specializing in dermatology. They hold a Doctorate in Pharmacy with a thesis focused on the clinical development of a biosimilar of adalimumab for treating psoriasis and psoriatic arthritis. Mathieu has gained experience in medical affairs and clinical operations at Fresenius Kabi and Sanofi-Aventis, where they worked on projects in areas such as thrombosis, diabetes, and infectious diseases. Additionally, they possess a Master's degree in Clinical Evaluation from the Institut de Pharmacie Industrielle de Lyon.
This person is not in the org chart
This person is not in any teams
This person is not in any offices